Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha.

[1]  J. Ingwall.  Energy metabolism in heart failure and remodelling. , 2008, Cardiovascular research.

[2]  S. Neubauer,et al.  Creatine uptake in mouse hearts with genetically altered creatine levels , 2008, Journal of molecular and cellular cardiology.

[3]  J. Ingwall,et al.  R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts. , 2007, Biophysical journal.

[4]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[5]  S. Neubauer,et al.  Supranormal Myocardial Creatine and Phosphocreatine Concentrations Lead to Cardiac Hypertrophy and Heart Failure: Insights From Creatine Transporter–Overexpressing Transgenic Mice , 2005, Circulation.

[6]  S. Neubauer,et al.  Alterations in the myocardial creatine kinase system precede the development of contractile dysfunction in beta(1)-adrenergic receptor transgenic mice. , 2003, Journal of molecular and cellular cardiology.

[7]  M. Wyss,et al.  Creatine and creatinine metabolism. , 2000, Physiological reviews.

[8]  J. Ingwall,et al.  Kinetic, Thermodynamic, and Developmental Consequences of Deleting Creatine Kinase Isoenzymes from the Heart , 2000, The Journal of Biological Chemistry.

[9]  S. Vatner,et al.  Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. , 1999, Circulation.

[10]  S. Vatner,et al.  β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse , 1999 .

[11]  S. Vatner,et al.  Apoptosis of Cardiac Myocytes in Gsα Transgenic Mice , 1999 .

[12]  G. Heusch,et al.  Inorganic phosphate content and free energy change of ATP hydrolysis in regional short-term hibernating myocardium. , 1998, Cardiovascular research.

[13]  S. Vatner,et al.  Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. , 1998, The Journal of clinical investigation.

[14]  J. Seidman,et al.  Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.

[15]  J. Ingwall,et al.  Regulation of cardiac AMP-specific 5'-nucleotidase during ischemia mediates ATP resynthesis on reflow. , 1998, American Journal of Physiology.

[16]  R. Starling,et al.  Human myocardial ATP content and in vivo contractile function , 1998, Molecular and Cellular Biochemistry.

[17]  J. Ingwall,et al.  Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. , 1996, Circulation research.

[18]  J. Ingwall,et al.  Energetic basis for reduced contractile reserve in isolated rat hearts. , 1996, The American journal of physiology.

[19]  S. Vatner,et al.  Adverse Effects of Chronic Endogenous Sympathetic Drive Induced by Cardiac Gsα Overexpression , 1996 .

[20]  Y. Ishikawa,et al.  Overexpression of Gs alpha protein in the hearts of transgenic mice. , 1995, The Journal of clinical investigation.

[21]  A. From,et al.  High-energy phosphate responses to tachycardia and inotropic stimulation in left ventricular hypertrophy. , 1994, The American journal of physiology.

[22]  G. Heusch,et al.  Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. , 1993, Circulation.

[23]  S. Neubauer,et al.  31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure , 1992, Circulation.

[24]  C. Hardy,et al.  Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. , 1991, American heart journal.

[25]  M. Weiner,et al.  Response of Myocardial Metabolites to Graded Regional Ischemia: 31P NMR Spectroscopy of Porcine Myocardium In Vivo , 1989, Circulation research.

[26]  J. Balschi,et al.  Effects of norepinephrine infusion on myocardial high-energy phosphate content and turnover in the living rat. , 1987, The Journal of clinical investigation.

[27]  J. Balschi,et al.  Contractile failure and high-energy phosphate turnover during hypoxia: 31P-NMR surface coil studies in living rat. , 1987, Circulation research.

[28]  J. Ingwall,et al.  Stabilization of a derangement in adenosine triphosphate metabolism during sustained, partial ischemia in the dog heart. , 1986, Journal of the American College of Cardiology.

[29]  C. Gibbs.  The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility. , 1985, Journal of molecular and cellular cardiology.

[30]  T R Brown,et al.  Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. , 1985, The American journal of physiology.

[31]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[32]  R. Veech,et al.  Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. , 1979, The Journal of biological chemistry.

[33]  J. Ingwall,et al.  Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency. , 2007, Journal of molecular and cellular cardiology.

[34]  H. Kammermeier.  Phosphorylation Potential and Free Energy of ATP , 1998 .

[35]  J. Ingwall,et al.  Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5'-nucleotidase. , 1994, The Journal of clinical investigation.